Federation des caisses Desjardins du Quebec’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-67	Closed	-$348	–	2627
2021 Q1	$348	Hold	67	–	–	﹤0.01%	2403
2020 Q4	$447	Hold	67	–	–	﹤0.01%	2272
2020 Q3	$682	Hold	67	–	–	﹤0.01%	2064
2020 Q2	$841	Hold	67	–	–	﹤0.01%	2002
2020 Q1	$734	Hold	67	–	–	﹤0.01%	2085
2019 Q4	$350	Hold	67	–	–	﹤0.01%	2254
2019 Q3	$482	Hold	67	–	–	﹤0.01%	2208
2019 Q2	$599	Hold	67	–	–	﹤0.01%	2180
2019 Q1	$653	Hold	67	–	–	﹤0.01%	1997
2018 Q4	$801	Hold	67	–	–	﹤0.01%	1972
2018 Q3	$1.08K	Hold	67	–	–	﹤0.01%	2038
2018 Q2	$2.42K	Hold	67	–	–	﹤0.01%	1999
2018 Q1	$2.08K	Hold	67	–	–	﹤0.01%	1988
2017 Q4	$2.58K	Buy	+67	New	+$1.76K	﹤0.01%	1970

Other funds holding BLPH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BLPH Position: Q2 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q2 2021, closing a stake of 67 shares — an estimated $348 sold.

Federation des caisses Desjardins du Quebec first reported a position in BLPH in Q4 2017 and held it in 14 quarters. The position peaked at $2.58K in Q4 2017. 27 funds tracked by Wall St. Rank hold BLPH as of Q2 2021.

Federation des caisses Desjardins du Quebec reported no remaining Bellerophon Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 67 Bellerophon Therapeutics, Inc. shares in Q2 2021, an estimated $348.
Federation des caisses Desjardins du Quebec first reported a position in Bellerophon Therapeutics, Inc. in Q4 2017 and held it in 14 quarters.
Federation des caisses Desjardins du Quebec's Bellerophon Therapeutics, Inc. position peaked at $2.58K in Q4 2017.
27 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q2 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2021, filed 30 Aug 2024.